Feed:Trial Acronyms: Difference between revisions

Jump to navigation Jump to search
no edit summary
No edit summary
No edit summary
Line 222: Line 222:
       "ESPRIT" : "European/Australasian Stroke Prevention in Reversible Ischaemia Trial",
       "ESPRIT" : "European/Australasian Stroke Prevention in Reversible Ischaemia Trial",
       "ATHOS-3" : "Angiotensin II for the Treatment of High-Output Shock",
       "ATHOS-3" : "Angiotensin II for the Treatment of High-Output Shock",
      "DINAMIT" : "Defibrillator in Acute Myocardial Infarction Trial",
       "ARISTOTLE" : "Apixaban for Reduction in Stroke and Other Thromboembolic Events in Atrial Fibrillation",
       "ARISTOTLE" : "Apixaban for Reduction in Stroke and Other Thromboembolic Events in Atrial Fibrillation",
       "PROWESS" : "Recombinant Human Activated Protein C Worldwide Evaluation in Severe Sepsis",
       "PROWESS" : "Recombinant Human Activated Protein C Worldwide Evaluation in Severe Sepsis",
Line 319: Line 320:
       "DIG" : "Digitalis Investigation Group",
       "DIG" : "Digitalis Investigation Group",
       "FLAME" : "Fluoxetine for Motor Recovery after Acute Ischaemic Stroke",
       "FLAME" : "Fluoxetine for Motor Recovery after Acute Ischaemic Stroke",
      "RABBIT 2" : "Randomized Study of Basal-Bolus Insulin Therapy in the Inpatient Management of Patients With Type 2 Diabetes",
       "METEOR" : "Meniscal Tear in Osteoarthritis Research",
       "METEOR" : "Meniscal Tear in Osteoarthritis Research",
      "RABBIT 2" : "Randomized Study of Basal-Bolus Insulin Therapy in the Inpatient Management of Patients With Type 2 Diabetes",
       "CORONA" : "Controlled Rosuvastatin Multinational Trial in Heart Failure",
       "CORONA" : "Controlled Rosuvastatin Multinational Trial in Heart Failure",
       "AF-CHF" : "Atrial Fibrillation and Congestive Heart Failure",
       "AF-CHF" : "Atrial Fibrillation and Congestive Heart Failure",
Line 340: Line 341:
       "HPTN 052" : "HIV Prevention Trials Network 052 Study",
       "HPTN 052" : "HIV Prevention Trials Network 052 Study",
       "SURTAVI" : "Safety and Efficacy Study of the Medtronic CoreValve System in the Treatment of Severe, Symptomatic Aortic Stenosis in Intermediate Risk Subjects Who Need Aortic Valve Replacement",
       "SURTAVI" : "Safety and Efficacy Study of the Medtronic CoreValve System in the Treatment of Severe, Symptomatic Aortic Stenosis in Intermediate Risk Subjects Who Need Aortic Valve Replacement",
      "OAT" : "Occluded Artery Trial",
       "EMPHASIS-HF" : "Eplerenone in Mild Patients Hospitalization and Survival Study in Heart Failure",
       "EMPHASIS-HF" : "Eplerenone in Mild Patients Hospitalization and Survival Study in Heart Failure",
       "POISE" : "PeriOperative ISchemic Evaluation",
       "POISE" : "PeriOperative ISchemic Evaluation",
Bots, editor, reviewer, Administrators
13,941

edits

Navigation menu